A randomized, double-blind, placebo-controlled, multicenter study to evaluate the cardioprotective effects of MC-1 in patients undergoing high-risk coronary artery bypass graft surgery: MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery Trial (MEND-CABG) II—study design and rationale

2008 ◽  
Vol 155 (4) ◽  
pp. 600-608 ◽  
Author(s):  
Rajendra H. Mehta ◽  
John H. Alexander ◽  
Robert Emery ◽  
Stephen J. Ellis ◽  
Vic Hasselblad ◽  
...  
2002 ◽  
Vol 96 (Sup 2) ◽  
pp. A162
Author(s):  
Shinichi Yamamoto ◽  
Tatsuya Yamada ◽  
Yoshifumi Kotake ◽  
Ryoichi Ochiai ◽  
Junzo Takeda

Sign in / Sign up

Export Citation Format

Share Document